This means that if IgG antibody is detected against AßP-42 in the blood of controls or AD patients, the probability of detecting high IgG antibody against amyloid ß protein, tau protein, α-synuclein, or GFAP in the same individual is more than 90%. Here, GFAP is linked to Alzheimer disease.